These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services? Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434 [No Abstract] [Full Text] [Related]
4. Clinical experience with Fluosol-DA (20%) in the United States. Tremper KK; Levine EM; Waxman K Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514 [No Abstract] [Full Text] [Related]
5. Perfluorochemical emulsion oxygen transport fluids: a clinical review. Tremper KK; Anderson ST Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055 [TBL] [Abstract][Full Text] [Related]
6. Current perspectives on blood substitutes. Gould SA; Moss G Curr Surg; 1987; 44(4):279-81. PubMed ID: 3665573 [No Abstract] [Full Text] [Related]
7. The protective effect of mannitol and perfluorochemicals on hemorrhagic infarction: an experimental study. Kagawa S; Koshu K; Yoshimoto T; Suzuki J Surg Neurol; 1982 Jan; 17(1):66-70. PubMed ID: 6803373 [No Abstract] [Full Text] [Related]
8. Can "artificial blood' live up to public billing? Cowart VS JAMA; 1982 Feb; 247(8):1104-5. PubMed ID: 7057595 [No Abstract] [Full Text] [Related]
9. [The place for using erythrocyte substitutes in hemodilution: fluosol-DA and polymerized pyridoxylated hemoglobin]. Vigneron C; Labrude P; Dellacherie E Ann Fr Anesth Reanim; 1986; 5(3):260-8. PubMed ID: 3535579 [TBL] [Abstract][Full Text] [Related]
10. Perfluorocarbons and haemoglobin solutions: will they ever reach clinical practice? Lamy M; Deby-Dupont G Acta Anaesthesiol Belg; 2003; 54(4):299-300. PubMed ID: 14719348 [No Abstract] [Full Text] [Related]
11. Role of the perfluorocarbon Fluosol-DA in coronary angioplasty. Kerins DM Am J Med Sci; 1994 Mar; 307(3):218-21. PubMed ID: 8160713 [No Abstract] [Full Text] [Related]
12. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients. Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428 [No Abstract] [Full Text] [Related]
13. Cardiovascular effects of various colloidal solutions during major abdominal surgery. Nishimura N; Hiranuma N; Sugi T Crit Care Med; 1983 Dec; 11(12):940-2. PubMed ID: 6196154 [TBL] [Abstract][Full Text] [Related]
15. Effect of hemodilution with dextran, stroma-free hemoglobin solution and fluosol-DA on experimental myocardial ischemia in the dog. Biro GP Bibl Haematol; 1981; (47):54-69. PubMed ID: 6175307 [No Abstract] [Full Text] [Related]
16. Blood substitutes: two ways to get there. Cowart VS JAMA; 1983 Jan; 249(2):159, 163-4. PubMed ID: 6848791 [No Abstract] [Full Text] [Related]
17. Blood substitutes as therapy in massive surgery and trauma. Tye RW Prog Clin Biol Res; 1982; 108():79-89. PubMed ID: 6817339 [No Abstract] [Full Text] [Related]
18. Current status of oxygen carriers ('blood substitutes'): 2006. Winslow RM Vox Sang; 2006 Aug; 91(2):102-10. PubMed ID: 16907870 [TBL] [Abstract][Full Text] [Related]
19. Blood substitutes in surgery. Cohn SM Surgery; 2000 Jun; 127(6):599-602. PubMed ID: 10840352 [No Abstract] [Full Text] [Related]